II. Definitions
- Kounis Syndrome
- Acute Coronary Syndrome triggered by an Allergic Reaction
III. Epidemiology
- Seen in ~1% of patients admitted with Allergic Reaction
IV. Pathophysiology
- First described in 1991 by Nicholas Kounis
-
Allergic Reaction cascade involving Mast Cell activation, Histamine release and Platelet aggregation
- Inflammatory reaction results in Coronary ArteryPlaque rupture resulting in Acute Coronary Syndrome
- Vasospasm may also be present
V. Findings
- Acute Coronary Syndrome onset within 1 hour of Allergic Reaction in 80% of cases
VI. Types
- Type 1: Vasospasm only
- Type 2: Vasospasm AND coronary thrombosis
- Type 3: Vasospasm AND stent thrombosis
VII. Management
- Manage as Acute Coronary Syndrome
- Manage Anaphylaxis
- Exercise caution with Anaphylaxis management that may provoke coronary disease (e.g. Epinephrine)
- Exercise caution with Acute Coronary Syndrome management that may provoke Allergic Reaction
- Beta Blockers may blunt Epinephrine response and Morphine (and other Opioids) may release Histamine
VIII. References
- Mattu and Demeester in Herbert (2021) EM:Rap 21(6): 3-4
- Kounis (1991) Br J Clin Pract 45:121-8 [PubMed]
- Memon (2015) Proc (Bayl Univ Med Cent) 28(3):358-62 [PubMed]